4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)
The present invention relates to a method for the reliable and reproducible preparation of 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MUELLER UWE BOHLMANN ULF GRAWE DETLEF HOESEL PETER GLIESING SABINE KNABE UWE JACKE JURGEN WEHMEIER DIETER VOIGTLAENDER DAVID MOSEBACH MICHAEL MICHEL THOMAS EILERS ROBERT BAHL KLAUS TILSTAM ULF SANDER MICHAEL GERECKE HAGEN ERHART BERND |
description | The present invention relates to a method for the reliable and reproducible preparation of 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013165421A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013165421A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013165421A13</originalsourceid><addsrcrecordid>eNrjZMgy0Y02NHdyDXHU9XUN8fCPiNQ1NHf0CfCA80FUpI-usa5_hL9rcEiQo66JjqWui6ern66hoS5YZ6RPrJOrX5Sjj4urR6SLq4KGqyZQtacvkOUY7B8Q5Bns5-mjycPAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4kODjQwMjQ3NTE2MDB0NjYlTBQAG0zZg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)</title><source>esp@cenet</source><creator>MUELLER UWE ; BOHLMANN ULF ; GRAWE DETLEF ; HOESEL PETER ; GLIESING SABINE ; KNABE UWE ; JACKE JURGEN ; WEHMEIER DIETER ; VOIGTLAENDER DAVID ; MOSEBACH MICHAEL ; MICHEL THOMAS ; EILERS ROBERT ; BAHL KLAUS ; TILSTAM ULF ; SANDER MICHAEL ; GERECKE HAGEN ; ERHART BERND</creator><creatorcontrib>MUELLER UWE ; BOHLMANN ULF ; GRAWE DETLEF ; HOESEL PETER ; GLIESING SABINE ; KNABE UWE ; JACKE JURGEN ; WEHMEIER DIETER ; VOIGTLAENDER DAVID ; MOSEBACH MICHAEL ; MICHEL THOMAS ; EILERS ROBERT ; BAHL KLAUS ; TILSTAM ULF ; SANDER MICHAEL ; GERECKE HAGEN ; ERHART BERND</creatorcontrib><description>The present invention relates to a method for the reliable and reproducible preparation of 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.).</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130627&DB=EPODOC&CC=US&NR=2013165421A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130627&DB=EPODOC&CC=US&NR=2013165421A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MUELLER UWE</creatorcontrib><creatorcontrib>BOHLMANN ULF</creatorcontrib><creatorcontrib>GRAWE DETLEF</creatorcontrib><creatorcontrib>HOESEL PETER</creatorcontrib><creatorcontrib>GLIESING SABINE</creatorcontrib><creatorcontrib>KNABE UWE</creatorcontrib><creatorcontrib>JACKE JURGEN</creatorcontrib><creatorcontrib>WEHMEIER DIETER</creatorcontrib><creatorcontrib>VOIGTLAENDER DAVID</creatorcontrib><creatorcontrib>MOSEBACH MICHAEL</creatorcontrib><creatorcontrib>MICHEL THOMAS</creatorcontrib><creatorcontrib>EILERS ROBERT</creatorcontrib><creatorcontrib>BAHL KLAUS</creatorcontrib><creatorcontrib>TILSTAM ULF</creatorcontrib><creatorcontrib>SANDER MICHAEL</creatorcontrib><creatorcontrib>GERECKE HAGEN</creatorcontrib><creatorcontrib>ERHART BERND</creatorcontrib><title>4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)</title><description>The present invention relates to a method for the reliable and reproducible preparation of 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.).</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZMgy0Y02NHdyDXHU9XUN8fCPiNQ1NHf0CfCA80FUpI-usa5_hL9rcEiQo66JjqWui6ern66hoS5YZ6RPrJOrX5Sjj4urR6SLq4KGqyZQtacvkOUY7B8Q5Bns5-mjycPAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4kODjQwMjQ3NTE2MDB0NjYlTBQAG0zZg</recordid><startdate>20130627</startdate><enddate>20130627</enddate><creator>MUELLER UWE</creator><creator>BOHLMANN ULF</creator><creator>GRAWE DETLEF</creator><creator>HOESEL PETER</creator><creator>GLIESING SABINE</creator><creator>KNABE UWE</creator><creator>JACKE JURGEN</creator><creator>WEHMEIER DIETER</creator><creator>VOIGTLAENDER DAVID</creator><creator>MOSEBACH MICHAEL</creator><creator>MICHEL THOMAS</creator><creator>EILERS ROBERT</creator><creator>BAHL KLAUS</creator><creator>TILSTAM ULF</creator><creator>SANDER MICHAEL</creator><creator>GERECKE HAGEN</creator><creator>ERHART BERND</creator><scope>EVB</scope></search><sort><creationdate>20130627</creationdate><title>4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)</title><author>MUELLER UWE ; BOHLMANN ULF ; GRAWE DETLEF ; HOESEL PETER ; GLIESING SABINE ; KNABE UWE ; JACKE JURGEN ; WEHMEIER DIETER ; VOIGTLAENDER DAVID ; MOSEBACH MICHAEL ; MICHEL THOMAS ; EILERS ROBERT ; BAHL KLAUS ; TILSTAM ULF ; SANDER MICHAEL ; GERECKE HAGEN ; ERHART BERND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013165421A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>MUELLER UWE</creatorcontrib><creatorcontrib>BOHLMANN ULF</creatorcontrib><creatorcontrib>GRAWE DETLEF</creatorcontrib><creatorcontrib>HOESEL PETER</creatorcontrib><creatorcontrib>GLIESING SABINE</creatorcontrib><creatorcontrib>KNABE UWE</creatorcontrib><creatorcontrib>JACKE JURGEN</creatorcontrib><creatorcontrib>WEHMEIER DIETER</creatorcontrib><creatorcontrib>VOIGTLAENDER DAVID</creatorcontrib><creatorcontrib>MOSEBACH MICHAEL</creatorcontrib><creatorcontrib>MICHEL THOMAS</creatorcontrib><creatorcontrib>EILERS ROBERT</creatorcontrib><creatorcontrib>BAHL KLAUS</creatorcontrib><creatorcontrib>TILSTAM ULF</creatorcontrib><creatorcontrib>SANDER MICHAEL</creatorcontrib><creatorcontrib>GERECKE HAGEN</creatorcontrib><creatorcontrib>ERHART BERND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MUELLER UWE</au><au>BOHLMANN ULF</au><au>GRAWE DETLEF</au><au>HOESEL PETER</au><au>GLIESING SABINE</au><au>KNABE UWE</au><au>JACKE JURGEN</au><au>WEHMEIER DIETER</au><au>VOIGTLAENDER DAVID</au><au>MOSEBACH MICHAEL</au><au>MICHEL THOMAS</au><au>EILERS ROBERT</au><au>BAHL KLAUS</au><au>TILSTAM ULF</au><au>SANDER MICHAEL</au><au>GERECKE HAGEN</au><au>ERHART BERND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)</title><date>2013-06-27</date><risdate>2013</risdate><abstract>The present invention relates to a method for the reliable and reproducible preparation of 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2013165421A1 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY STEROIDS |
title | 4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A06%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MUELLER%20UWE&rft.date=2013-06-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013165421A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |